Chronic hepatitis C in HIV infection: Feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin

AIDS

Volumn 15, Issue 14, 2001, Pages 1783-1787

  Nasti, Guglielmo ^a   Di Gennaro, Giampiero ^a   Tavio, Marcello ^a   Cadorin, Lucia ^a   Tedeschi, Rosa Maria ^a   Talamini, Renato ^a   Carbone, Antonino ^a   Tirelli, Umberto ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Chronic hepatitis C; Co infection; Combination therapy; HIV; Interferon ; Ribavirin; Tribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; LIVER ENZYME; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FUNCTION; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME;

EID: 0035964689     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200109280-00006     Document Type: Article

References (11)

1. Management of chronic hepatitis C in HIV-infected patients
2. Diagnosis and treatment of hepatic disease in patients with HIV
3. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study
4. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study
5. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
6. Efficacy and safety of combination therapy with interferon-a2b and ribavirin for chronic hepatitis C in HIV-infected patients
7. Formulation and application of a numerical scoring system for assessing histological activity in asymtomatic chronic active hepatitis
8. Impact of treatment with HIV protease inhibitors of hepatitis C viremia in patients co-infected with HIV
9. Interferon alfa for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus
10. Impact of antiretroviral therapy on hepatitis C viremia in HIV-infected patients
11. Randomised trial of interferon alfa-2b plus ribavirin for 48 weeks or 24 weeks versus interferon alfa-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus